Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1400 CAD | 0.00% |
|
-6.67% | +7.69% |
| Market Cap | 52.87M 37.21M 32.58M 30.08M 28.09M 3.52B 54.07M 362M 140M 1.74B 140M 137M 6.03B | P/E 2026 * |
-4.67x | P/E 2027 * | -3.5x |
|---|---|---|---|---|---|
| Enterprise Value | 52.87M 37.21M 32.58M 30.08M 28.09M 3.52B 54.07M 362M 140M 1.74B 140M 137M 6.03B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.6x |
| Free-Float |
86.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -6.67% | ||
| 3 months | -17.65% | ||
| 6 months | +7.69% | ||
| Current year | +7.69% |
| 1 week | 0.12 |  | 0.16 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tanya Lewis
BRD | Director/Board Member | 55 | - |
John Brooks
CHM | Chairman | 75 | 23/09/2025 |
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/05 | Option | Chairman | 360,000 | 0.1035% | ||
| 22/05 | Option | Director | 260,000 | 0.0748% | ||
| 22/05 | Option | Chairman | 228,912 | 0.0658% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.67% | -15.15% | -84.62% | 37.26M | |
| -0.66% | +8.48% | -16.46% | +9.53% | 128B | |
| +0.44% | +1.64% | +3.11% | -9.39% | 12.77B | |
| -1.54% | +8.38% | +37.66% | +100.80% | 8.48B | |
| +3.27% | -3.35% | -48.73% | -72.12% | 3.79B | |
| +2.94% | +1.94% | +21.28% | +39.81% | 2.52B | |
| +6.68% | +11.48% | +238.24% | +166.10% | 1.55B | |
| +20.00% | +4.10% | -11.29% | -12.29% | 1.53B | |
| +4.97% | +1.32% | +3.29% | -19.66% | 1.53B | |
| Average | +4.06% | +2.66% | +23.55% | +13.13% | 17.75B | |
| Weighted average by Cap. | +0.12% | +7.22% | -9.48% | +12.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.52M 3.08M 2.84M 2.66M 333M 5.11M 34.23M 13.21M 164M 13.21M 12.92M 570M |
| Net income | -12.83M -9.03M -7.9M -7.3M -6.81M -853M -13.12M -87.81M -33.9M -421M -33.9M -33.16M -1.46B | -19.77M -13.91M -12.18M -11.25M -10.5M -1.32B -20.22M -135M -52.25M -649M -52.26M -51.11M -2.25B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | CAD 0.1400 | 0.00% | 213,550 |
| 25/06/26 | CAD 0.1400 | 0.00% | 17,500 |
| 24/06/26 | CAD 0.1400 | -3.45% | 208,654 |
| 23/06/26 | CAD 0.1450 | -6.45% | 63,778 |
| 22/06/26 | CAD 0.1550 | +3.33% | 78,770 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1400CAD
Average target price
0.4500CAD
Spread / Average Target
+221.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
